524P A phase I, open-label, dose-escalation trial of BI 1701963 in patients (pts) with KRAS mutated solid tumours: A snapshot analysis
Autor: | Johnson, M.L., Gort, E., Pant, S., Lolkema, M.P., Sebastian, M., Scheffler, M., Hwang, J., Dünzinger, U., Riemann, K., Kitzing, T., Jänne, P.A. |
---|---|
Zdroj: | In Annals of Oncology September 2021 32 Supplement 5:S591-S592 |
Databáze: | ScienceDirect |
Externí odkaz: |